文献速递关节外科骨肿瘤

全膝关节置换术中发现晚期膝关节腱鞘巨细胞瘤的预后

Prognosis of Advanced Tenosynovial Giant Cell Tumor of the Knee Diagnosed During Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2017-01-11

研究纳入2008年1月至2011年7月因初诊骨关节炎行后稳定型全膝关节置换术、术中偶然确诊腱鞘巨细胞瘤(TGCT)的10例患者(共11膝),局限型3膝行部分滑膜切除、弥漫型8膝行全滑膜切除。平均随访60.9±6.6个月,无TGCT复发,假体周围无透亮线及松动、下沉或骨溶解,关节活动度与膝关节学会评分均显著改善。

要点

  • 术中偶然确诊的晚期TGCT在术前无法诊断,全膝关节置换联合滑膜切除治疗有效。
  • 平均随访60.9±6.6个月无TGCT复发,无感染、神经损伤或深静脉血栓。
  • 术后活动度及膝关节学会膝关节与功能评分均较术前显著改善(P<.01)。

核心结论

  • 非活动性TGCT术前无法诊断,全膝关节置换联合滑膜切除对伴退行性病变的晚期TGCT治疗有效。

研究设计与样本

  • 2008年1月至2011年7月因初诊骨关节炎行后稳定型全膝关节置换术、术中偶然确诊TGCT的10例患者共11膝,经组织病理学确认;局限型3膝(3例)行部分滑膜切除,弥漫型8膝(7例)行全滑膜切除。

主要发现

  • 所有患者均为女性,平均年龄61.7±6.6岁(范围50-70岁)。
  • 无术后感染、神经损伤或深静脉血栓发生;平均随访60.9±6.6个月(范围39-83个月),无TGCT复发。
  • X线显示假体周围无明显透亮线,无假体松动、下沉或骨溶解;关节稳定。
  • 术后关节活动度较术前显著改善(109.5°±8.8° vs 80.5°±16.8°,P<.01)。
  • 术后膝关节学会膝关节评分(90.0±4.1 vs 40.5±8.1)与功能评分(81.8±7.5 vs 35.0±13.8)均较术前显著改善(P<.01)。

临床怎么用

  • 原文结论认为全膝关节置换联合滑膜切除对伴退行性病变的晚期TGCT治疗有效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tenosynovial giant cell tumor (TGCT) is a relatively rare disease often misdiagnosed as osteoarthritis. Synovectomy or arthroplasty is the recommended treatment option, but recurrence is common after surgery. This study aimed to determine the prognosis of patients with advanced TGCT that was diagnosed incidentally during total knee arthroplasty (TKA) for osteoarthritis and treated by synovectomy. METHODS: From January 2008 to July 2011, TGCT was diagnosed incidentally in 10 patients (a total of 11 individual knees) undergoing posterior-stabilized TKA for an initial diagnosis of osteoarthritis. TGCT was confirmed by histopathology of biopsy specimens. Partial synovectomy was performed for localized-type TGCT (3 knees, 3 patients) and total synovectomy for diffuse-type TGCT (8 knees, 7 patients). RESULTS: All patients were female with a mean age of 61.7 ± 6.6 (range 50-70) years. No postoperative infection, nerve injury, or deep venous thrombosis occurred. All patients were followed up for a mean period of 60.9 ± 6.6 (39-83) months, and no recurrence of TGCT occurred. X-ray imaging showed no apparent radiolucent lines around the prosthesis, and no prosthetic loosening, subsidence, or osteolysis. The joints were stable, with a significantly improved range of motion following surgery (109.5° ± 8.8° vs 80.5° ± 16.8°, P < .01). The Knee Society scores for knee joint (90.0 ± 4.1 vs 40.5 ± 8.1) and knee function (81.8 ± 7.5 vs 35.0 ± 13.8) were both significantly improved after surgery (P < .01). CONCLUSION: Inactive TGCT could not be diagnosed preoperatively. TKA combined with synovectomy is effective in the treatment of advanced TGCT with degenerative lesions.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Lei P, Sun R, Liu H, et al. Prognosis of Advanced Tenosynovial Giant Cell Tumor of the Knee Diagnosed During Total Knee Arthroplasty. J Arthroplasty. 2017. PMID: 28161138. doi:10.1016/j.arth.2016.12.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。